DDC Enterprise [DDC] vs Bioharvest Sciences [BHST] Detailed Stock Comparison
TLDR: Quick Comparison Summary
Based on 19 vital metrics comparison: DDC Enterprise Ltd. wins in 7 metrics, Bioharvest Sciences Inc. wins in 10 metrics, with 0 ties. Bioharvest Sciences Inc. appears stronger overall.
View Metrics Details
Vital Metrics Comparison
| Metric | DDC Enterprise Ltd. | Bioharvest Sciences Inc. | Better |
|---|---|---|---|
| P/E Ratio (TTM) | 0.38 | -7.30 | DDC Enterprise Ltd. |
| Price-to-Book Ratio | 0.62 | 3.90 | DDC Enterprise Ltd. |
| Debt-to-Equity Ratio | 42.72 | 55.42 | DDC Enterprise Ltd. |
| PEG Ratio | N/A | -51.53 | N/A |
| EV/EBITDA | -1.88 | -17.68 | DDC Enterprise Ltd. |
| Profit Margin (TTM) | -123.34% | -32.27% | Bioharvest Sciences Inc. |
| Operating Margin (TTM) | -147.74% | -12.37% | Bioharvest Sciences Inc. |
| Return on Equity | -106.65% | -83.17% | Bioharvest Sciences Inc. |
| Return on Assets (TTM) | -14.96% | -9.59% | Bioharvest Sciences Inc. |
| Free Cash Flow (TTM) | $-737.37M | $-9.58M | Bioharvest Sciences Inc. |
| 1-Year Return | -81.41% | -38.34% | Bioharvest Sciences Inc. |
| Price-to-Sales Ratio (TTM) | 0.33 | 2.88 | DDC Enterprise Ltd. |
| Enterprise Value | $61.41M | $90.35M | Bioharvest Sciences Inc. |
| EV/Revenue Ratio | 1.53 | 2.62 | DDC Enterprise Ltd. |
| Gross Profit Margin (TTM) | 19.07% | 57.63% | Bioharvest Sciences Inc. |
| Revenue per Share (TTM) | $26 | $2 | DDC Enterprise Ltd. |
| Earnings per Share (Diluted) | $-5.70 | $-0.60 | Bioharvest Sciences Inc. |
| Beta (Stock Volatility) | N/A | 1.40 | N/A |
| Short % of Float | 8.30% | 0.34% | Bioharvest Sciences Inc. |
DDC Enterprise Ltd. vs Bioharvest Sciences Inc. Stock Performance Analysis
Loading Price Chart...
Performance Comparison
Short-term Returns
| Stock | 1D | 1W | 1M | 3M | 6M | YTD |
|---|---|---|---|---|---|---|
| DDC Enterprise Ltd. | -7.16% | -4.84% | -26.25% | -48.02% | -64.67% | -44.08% |
| Bioharvest Sciences Inc. | -1.66% | -9.18% | -14.01% | -19.09% | -45.40% | -31.67% |
Long-term Returns
| Stock | 1Y | 3Y | 5Y | 10Y | 15Y | 20Y |
|---|---|---|---|---|---|---|
| DDC Enterprise Ltd. | -81.41% | -99.07% | -99.07% | -99.07% | -99.07% | -99.07% |
| Bioharvest Sciences Inc. | -38.34% | -35.67% | -35.67% | -35.67% | -35.67% | -35.67% |
Performance & Financial Health Analysis: DDC Enterprise Ltd. vs Bioharvest Sciences Inc.
| Metric | DDC | BHST |
|---|---|---|
| Market Information | ||
| Market Cap | $80.58M | $99.29M |
| Market Cap Category | Micro cap | Micro cap |
| 10 Day Avg. Volume | 97,044 | 14,610 |
| 90 Day Avg. Volume | 66,895 | 23,620 |
| Last Close | $1.18 | $3.56 |
| 52 Week Range | $1.08 - $20.83 | $3.54 - $12.80 |
| % from 52W High | -94.33% | -72.19% |
| All-Time High | $20.83 (Jul 14, 2025) | $12.80 (Oct 07, 2025) |
| % from All-Time High | -94.34% | -72.19% |
| Growth Metrics | ||
| Quarterly Revenue Growth | 0.08% | 0.25% |
| Quarterly Earnings Growth | -0.88% | 0.25% |
| Financial Health | ||
| Profit Margin (TTM) | -1.23% | -0.32% |
| Operating Margin (TTM) | -1.48% | -0.12% |
| Return on Equity (TTM) | -1.07% | -0.83% |
| Debt to Equity (MRQ) | 42.72 | 55.42 |
| Cash & Liquidity | ||
| Book Value per Share (MRQ) | $3.27 | $1.12 |
| Cash per Share (MRQ) | $6.05 | $1.02 |
| Operating Cash Flow (TTM) | $-40,659,518 | $-7,226,000 |
| Levered Free Cash Flow (TTM) | $31.39M | $-10,782,250 |
| Dividends | ||
| Last 12-Month Dividend Yield | N/A | N/A |
| Last 12-Month Dividend | N/A | N/A |
Valuation & Enterprise Metrics Analysis: DDC Enterprise Ltd. vs Bioharvest Sciences Inc.
| Metric | DDC (Apr 24, 2026) | BHST (Apr 26, 2026) |
|---|---|---|
| Price Ratios | ||
| P/E Ratio (TTM) | 0.38 | -7.30 |
| Forward P/E | N/A | -51.53 |
| PEG Ratio | N/A | -51.53 |
| Price to Sales (TTM) | 0.33 | 2.88 |
| Price to Book (MRQ) | 0.62 | 3.90 |
| Market Capitalization | ||
| Market Capitalization | $80.58M | $99.29M |
| Enterprise Value | $61.41M | $90.35M |
| Enterprise Value Metrics | ||
| Enterprise to Revenue | 1.53 | 2.62 |
| Enterprise to EBITDA | -1.88 | -17.68 |
| Risk & Other Metrics | ||
| Beta | N/A | 1.40 |
| Book Value per Share (MRQ) | $3.27 | $1.12 |
Financial Statements Comparison: DDC Enterprise Ltd. vs Bioharvest Sciences Inc.
Financial Metrics
Loading Financial Charts...
Revenue
Operating Margin
Profit Margin
Long Term Debt
Income Flow Analysis
Financial Statements Comparison
Income Statement
| Metric | DDC (2025) | BHST (2025) |
|---|---|---|
| Revenue/Sales | 274.04M | 34.51M |
| Cost of Goods Sold | 187.89M | 14.03M |
| COGS % of Revenue | 68.6% | 40.7% |
| Gross Profit | 86.15M | 20.48M |
| Gross Margin | 31.4% | 59.3% |
| Research & Development | N/A | 5.31M |
| Operating Income (EBIT) | -225.04M | -5.58M |
| Operating Margin | -82.1% | -16.2% |
| EBITDA | -211.99M | -4.88M |
| EBITDA Margin | -77.4% | -14.1% |
| Pre-Tax Income | -323.34M | -11.06M |
| Pre-Tax Income % of Revenue | -118.0% | -32.0% |
| Income Tax | 14.66M | 76,000 |
| Income Tax % of Revenue | 5.4% | 0.2% |
| Net Income (Profit) | -338.00M | -11.14M |
| Profit Margin | -123.3% | -32.3% |
Balance Sheet & Liquidity Metrics
| Metric | DDC (2025) | BHST (2025) |
|---|---|---|
| Cash & Equivalents | 21.12M | 23.03M |
| Total Current Assets | 585.14M | 30.50M |
| Total Current Assets % of Revenue | 213.5% | 88.4% |
| Total Current Liabilities | 668.03M | 7.68M |
| Total Current Liabilities % of Revenue | 243.8% | 22.3% |
| Long-Term Debt | 164.27M | 12.55M |
| Long-Term Debt % of Revenue | 59.9% | 36.4% |
| Total Shareholders Equity | 551.60M | 25.45M |
| Retained Earnings | -2.17B | -107.55M |
| Retained Earnings % of Revenue | -792.3% | -311.7% |
| Property, Plant & Equipment | 12.05M | 830,000 |
Cash Flow Statement Comparison
| Metric | DDC (2025) | BHST (2025) |
|---|---|---|
| Operating Cash Flow | -98.14M | -7.71M |
| Operating Cash Flow % of Revenue | -35.8% | -22.3% |
| Capital Expenditures | -31,988 | -2.36M |
| Free Cash Flow | -737.37M | -9.58M |
| FCF Margin | -269.1% | -27.8% |
| Debt Repayment | -78.62M | -7.15M |
| Common Stock Repurchase | N/A | N/A |
Short Interest & Institutional Ownership Analysis
| Metric | DDC | BHST |
|---|---|---|
| Shares Short | 106,054 | 65,292 |
| Short Ratio | 1.60 | 2.41 |
| Short % of Float | 8.30% | 0.34% |
| Shares Outstanding | 23.28M | 22.67M |
| Float Shares | 14.70M | 17.82M |
| % Held by Insiders | 34.61% | 16.60% |
| % Held by Institutions | 0.21% | 8.28% |
| % Held by Public | 65.18% | 75.12% |
Dividend Analysis & Yield Comparison: DDC Enterprise Ltd. vs Bioharvest Sciences Inc.
| Metric | DDC | BHST |
|---|---|---|
| Last 12-Month Dividend | N/A | N/A |
| Last 12-Month Dividend Yield | N/A | N/A |
| 3-Year Avg Annual Dividend | N/A | N/A |
| 3-Year Avg Dividend Yield | N/A | N/A |
| 3-Year Total Dividends | N/A | N/A |
| Ex-Dividend Date | N/A | N/A |